JOSE XAVIER PLUGUEZ

Allopathic & Osteopathic Physicians|General Practice DAVENPORT, FL NPI 1922158476

General Payments — all program years on this page

$697.07

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 33
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $354.99 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $354.9920

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $79.041
2019 $55.632
2020 $20.061
2021 $50.401
2023 $136.958
2024 $354.9920

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086189536 Bayer Healthcare Pharmaceuticals Inc. $17.43 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104520104 AstraZeneca Pharmaceuticals LP $13.35 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104632356 AstraZeneca Pharmaceuticals LP $16.80 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104762374 AstraZeneca Pharmaceuticals LP $14.29 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105281000 ABBVIE INC. $17.65 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105810949 AstraZeneca Pharmaceuticals LP $13.15 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116233892 GlaxoSmithKline, LLC. $13.59 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117355087 Amgen Inc. $21.67 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117355089 Amgen Inc. $19.08 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118236114 Boehringer Ingelheim Pharmaceuticals, Inc. $13.72 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118236116 Boehringer Ingelheim Pharmaceuticals, Inc. $27.91 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125338792 Abbott Laboratories $25.55 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135074037 Lilly USA, LLC $19.14 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135074039 Lilly USA, LLC $14.25 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135080210 Lilly USA, LLC $18.48 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135102093 Lilly USA, LLC $16.46 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148904605 Sumitomo Pharma America, Inc. $24.26 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150135173 SHIELD THERAPEUTICS INC $14.78 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153311109 Dexcom, Inc. $17.29 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153683085 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.14 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.